Charged particle therapy is the most advanced type of radiotherapy in oncology. Recent evidence from randomized clinical trials shows that particles can reduce toxicity and improve survival in selected patients. Particle therapy is very sensitive to positioning uncertainties and organ movements, however, which can jeopardize its precision. In this webinar, we will introduce the rationale for therapy with accelerated ions, review recent clinical evidence, and show new preclinical experiments that reduce range uncertainties. These experiments use radioactive ion beams (carbon-11 ions) that can be visualized by positron emission tomography (PET)—an “aim-and-shoot” approach that allows real-time adaptation during the treatment.

Attendee learning outcomes:

• The physical and biological rationale for particle therapy in oncology
• Clinical results showing superiority of particle therapy compared to conventional x rays
• Radioactive ion beams in therapy
• Adaptive radiotherapy with radioactive ions

Who Should Attend:

• Physicists (medical physicists, nuclear physicists)
• Medical doctors (oncologists)
• Biomedical engineers